Discover
EVOK
Evoke Pharma, Inc.
11.00
2 x 7.90
2 x 14.06
bid
ask
+
0.00
0.00%
2 @ 04:00 PM
11.00 -0.00 (0.00%)
| Ytd | 148.87% | |
| 1y | 139.65% |
10.98
day range
11.00
3.54
52 week range
14.04
| Open | 10.98 | Prev Close | 11.00 | Low | 10.98 | High | 11.00 | Mkt Cap | 7.37M |
| Vol | 47.10K | Avg Vol | 395.00K | EPS | -10.13 | P/E | N/A | Forward P/E | 10.33 |
| Beta | 0.35 | Short Ratio | 0.24 | Inst. Own | 17.13% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 4.97 | 200-d Avg | 5.60 | 1yr Est | 18.00 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2024-11-07 | 2024-09 | 0 | -0.94 | N/A | N/A |
| 2024-08-13 | 2024-06 | 0 | -0.93 | N/A | N/A |
| 2024-05-14 | 2024-03 | 0 | -2.04 | N/A | N/A |
| 2024-03-14 | 2023-12 | 0 | -7.08 | N/A | N/A |
| 2023-11-09 | 2023-09 | 0 | -6.12 | N/A | N/A |
| 2023-08-10 | 2023-06 | 0 | -6.72 | N/A | N/A |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|
Profile
Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | AIGH Capital Management LLC | 70.55K | 349.91K | 4.75% |
| 2024-09-29 | Bleichroeder LP | 68.75K | 341.00K | 4.63% |
| 2024-09-29 | Nantahala Capital Management, LLC | 56.25K | 279.00K | 3.79% |
| 2024-09-29 | Corsair Capital Management, L.P. | 11.67K | 57.87K | 0.79% |
| 2024-09-29 | Tower Research Capital LLC (TRC) | 816.00 | 4.05K | 0.05% |
| 2024-09-29 | Blackrock Inc. | 122.00 | 605.00 | 0.01% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Vanguard Extended Market Index Fund | 2.49K | 12.34K | 0.17% |
| 2024-10-30 | Fidelity Extended Market Index Fund | 2.40K | 11.92K | 0.16% |
| 2024-10-30 | Fidelity Series Total Market Index Fund | 1.50K | 7.42K | 0.10% |
| 2024-10-30 | Fidelity NASDAQ Composite Index Fund | 373.00 | 1.85K | 0.03% |
| 2024-10-30 | Fidelity Total Market Index Fund | 41.00 | 203.00 | 0.00% |
Split
| Split | Date |
|---|---|
| 1 : 12 | 2024-08-01 |
| 1 : 12 | 2022-05-23 |